Correlation Between Alcoa Corp and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both Alcoa Corp and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alcoa Corp and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alcoa Corp and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Alcoa Corp and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alcoa Corp with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alcoa Corp and NLS Pharmaceutics.
Diversification Opportunities for Alcoa Corp and NLS Pharmaceutics
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Alcoa and NLS is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Alcoa Corp and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Alcoa Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alcoa Corp are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Alcoa Corp i.e., Alcoa Corp and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between Alcoa Corp and NLS Pharmaceutics
Allowing for the 90-day total investment horizon Alcoa Corp is expected to generate 0.13 times more return on investment than NLS Pharmaceutics. However, Alcoa Corp is 7.56 times less risky than NLS Pharmaceutics. It trades about 0.24 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about 0.02 per unit of risk. If you would invest 4,009 in Alcoa Corp on September 1, 2024 and sell it today you would earn a total of 634.00 from holding Alcoa Corp or generate 15.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alcoa Corp vs. NLS Pharmaceutics AG
Performance |
| Timeline |
| Alcoa Corp |
| NLS Pharmaceutics |
Alcoa Corp and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alcoa Corp and NLS Pharmaceutics
The main advantage of trading using opposite Alcoa Corp and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alcoa Corp position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.| Alcoa Corp vs. Fortitude Gold Corp | Alcoa Corp vs. New Gold | Alcoa Corp vs. Galiano Gold | Alcoa Corp vs. GoldMining |
| NLS Pharmaceutics vs. Reviva Pharmaceuticals Holdings | NLS Pharmaceutics vs. GeoVax Labs | NLS Pharmaceutics vs. NLS Pharmaceutics AG | NLS Pharmaceutics vs. Lixte Biotechnology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |